Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-02-08Clinical Trial Update: Study to Evaluate the Safety and Efficacy of PB-201 in Treatment-naive Patients With Type 2 Diabetes Mellitus [Phase 3]
Phase 3 study assessing safety and efficacy of PB-201 in treatment-naive adults with type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2022-02-04Clinical Trial Update: Long Term Daily Use of JARDIANCE® Tablets in Japanese Patients With Type 2 Diabetes Mellitus
Long-term daily use study of JARDIANCE tablets in Japanese adults with Type 2 diabetes completed; results posted in 2022.
-
FDA approval · 2022-02-03FDA Approved: DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application from Prasco Laboratories to market a fixed-dose combination tablet of dapagliflozin and metformi…
-
CLINICAL_TRIALS withdrawal · 2022-02-03Clinical Trial Update: SUSTAIN SWITCH: A Research Study to Compare Two Dose Schedules of Semaglutide Taken Once Weekly in People With Type 2 Diabetes [Phase 3]
A Phase 3 trial evaluating two weekly dose schedules of semaglutide in Type 2 diabetes has been withdrawn.
-
CLINICAL_TRIALS research · 2022-02-01Clinical Trial Update: The Health Influences of Puberty (HIP) Study [Phase 4]
Phase 4 clinical trial update on the Health Influences of Puberty (HIP) study, investigating obesity and metabolic-related conditions in ado…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-01-28Clinical Trial Update: Efficacy and Safety of Teneligliptin in Combination With Metformin in Chinese Patients With Type 2 Diabetes Mellitus [Phase 3]
A Phase 3 trial assessed the efficacy and safety of adding teneligliptin to metformin in Chinese patients with Type 2 Diabetes Mellitus.
-
CLINICAL_TRIALS trial_result · 2022-01-28Clinical Trial Update: Efficacy and Safety of Teneligliptin in Chinese Patients With Type 2 Diabetes Mellitus [Phase 3]
A Phase 3 study assessing the efficacy and safety of teneligliptin in Chinese patients with type 2 diabetes mellitus has completed, with res…
-
CLINICAL_TRIALS trial_result · 2022-01-27Clinical Trial Update: Comparisons of Metabolic Effect of Sleeve Gastrectomy With Duodenojejunal Bypass and Sleeve Gastrectomy (MEDUSA): A Multicenter Randomized Controlled Trial [Phase 3]
A Phase 3 randomized trial (MEDUSA) compares metabolic effects of sleeve gastrectomy with duodenojejunal bypass versus sleeve gastrectomy al…
-
CLINICAL_TRIALS trial_result · 2022-01-20Clinical Trial Update: Glucose-Lowering Effects and Safety of Adding 0.25 or 0.5 mg Duvie [Phase 4]
Phase 4 trial update evaluating glucose-lowering effects and safety of adding 0.25 or 0.5 mg Duvie in adults with Type 2 Diabetes Mellitus a…
-
CLINICAL_TRIALS trial_result · 2022-01-19Clinical Trial Update: A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes [Phase 3]
Phase 3 trial comparing Tirzepatide (LY3298176) to Insulin Degludec in adults with Type 2 Diabetes; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-01-19Clinical Trial Update: Clinical Trial With Broccoli Sprout Extract to Patients With Type 2 Diabetes [Phase 2]
Phase 2 clinical trial assessing broccoli sprout extract in patients with non-insulin-dependent diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2022-01-18Clinical Trial Update: Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise [Phase 3]
Phase 3 trial comparing efpeglenatide to placebo in adults with type 2 diabetes inadequately controlled with diet and exercise; study comple…
-
CLINICAL_TRIALS trial_result · 2022-01-18Clinical Trial Update: Kidney Fat in Type 2 Diabetes and the Effects of Ezetimibe [Phase 3]
Phase 3 trial investigating the effects of ezetimibe on kidney fat in type 2 diabetes with diabetic kidney disease.
-
CLINICAL_TRIALS trial_result · 2022-01-14Clinical Trial Update: Renal Actions of Combined Empagliflozin and LINagliptin in Type 2 diabetES [Phase 4]
Phase 4 trial update on the renal effects of combining empagliflozin and linagliptin in type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2022-01-12Clinical Trial Update: A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin [Phase 3]
Phase 3 trial comparing tirzepatide to placebo in type 2 diabetes patients inadequately controlled on insulin glargine, with or without metf…
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: Effects of Empagliflozin on Exercise Capacity and Left Ventricular Diastolic Function in Patients With Heart Failure With Preserved Ejection Fraction and Type-2 Diabetes Mellitus [Phase 4]
Phase 4 trial assessing the impact of empagliflozin on exercise capacity and left ventricular diastolic function in patients with heart fail…
-
CLINICAL_TRIALS trial_result · 2022-01-04Clinical Trial Update: Triple Combination Therapy in Type 2 Diabetic Patients Who Had Inadequate Glycemic Control With Combination Therapy [Phase 4]
Phase 4 clinical trial update evaluating triple combination therapy in type 2 diabetes patients with inadequate glycemic control on prior co…
-
CLINICAL_TRIALS research · 2022-01-03Clinical Trial Update: Cognitive Behavioral Therapy for African Americans With Uncontrolled Type-2 Diabetes [NA]
Clinical trial update on CBT for African Americans with uncontrolled type 2 diabetes; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2021-12-29Clinical Trial Update: A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM) [Phase 2]
Phase 2 study of HTD1801 in adults with nonalcoholic steatohepatitis (NASH) and type 2 diabetes mellitus (T2DM) completed; results posted in…
-
FDA approval · 2021-12-17FDA Approved: REZVOGLAR KWIKPEN — Original Application (Eli Lilly and Company)
The FDA approved Rezvoglar KwikPen (insulin glargine-AGLR) from Eli Lilly as an original application, providing a long-acting insulin option…
-
CLINICAL_TRIALS trial_result · 2021-12-16Clinical Trial Update: Safety and Efficacy of THR-1442 Compared to Dapagliflozin as Add-on Therapy to Metformin in T2DM [Phase 3]
Phase 3 trial evaluating safety and efficacy of THR-1442 as add-on to metformin versus dapagliflozin in type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2021-12-15Clinical Trial Update: Dapagliflozin Effect on Erythropoiesis and Physical Fitness [Phase 4]
Phase 4 trial update on dapagliflozin focusing on erythropoiesis and physical fitness has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2021-12-13Clinical Trial Update: Social Media-Delivered Patient Education in Enhancing Type 2 Diabetics Self-Management and Attitudes During the COVID-19 Pandemic [NA]
A completed clinical trial evaluating social media-delivered patient education to improve self-management and attitudes in adults with type …
-
CLINICAL_TRIALS trial_result · 2021-12-10Clinical Trial Update: Efficacy and Safety of Evogliptin When Added to Ongoing Metformin and Dapagliflozin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control [Phase 3]
Phase 3 trial evaluating the efficacy and safety of evogliptin added to ongoing metformin and dapagliflozin in adults with type 2 diabetes a…
-
CLINICAL_TRIALS trial_result · 2021-12-07Clinical Trial Update: A Phase IV Study in Drug-Naive Patients With T2DM in China [Phase 4]
Phase IV study in drug-naive patients with type 2 diabetes mellitus conducted in China has been terminated.